Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lone Storgaard1, Ulla Brix-Tange2, Lotte Berdiin Colmorn3

  • 1Afdeling for Graviditet, Fødsel og Barsel, Københavns Universitetshospital - Rigshospitalet.

Ugeskrift for Laeger
|February 8, 2024
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic and treatment delay in women with cancer in pregnancy: a case-based study.

Archives of gynecology and obstetrics·2026
Same author

AI-assisted image analysis of tumor-infiltrating lymphocytes as a prognostic marker in chemotherapy-naïve luminal breast cancer.

NPJ breast cancer·2026
Same author

Prognostic value of the SENTIREC-endo algorithm integrating sentinel lymph node and FDG-PET/CT in staging high-risk endometrial cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Very early [<sup>18</sup>F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trial.

The Lancet. Haematology·2026
Same author

Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer.

In vivo (Athens, Greece)·2026
Same author

Improved survival with fludarabine-based therapies in mixed phenotype acute leukaemia: A population-based study using the WHO 2022 classification.

British journal of haematology·2026
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles
This summary is machine-generated.

Managing cancer during pregnancy is challenging due to limited physician knowledge. This review highlights current understanding and the establishment of advisory boards for improved care of pregnant cancer patients.

Area of Science:

  • Oncology
  • Maternal-Fetal Medicine
  • Public Health

Background:

  • Cancer in pregnancy is a rare occurrence, often leading to a knowledge gap among healthcare providers regarding optimal management strategies.
  • Physicians frequently encounter difficulties in navigating the complexities of treating cancer in pregnant individuals, necessitating specialized guidance and support.

Approach:

  • This review synthesizes current medical knowledge on managing cancer in pregnant patients.
  • It details the establishment and function of advisory boards dedicated to cancer in pregnancy, starting with the Netherlands in 2012.
  • It highlights the recent formation of the International Advisory Board on Cancer in Pregnancy and the Danish Advisory Board on Cancer in Pregnancy (DABCIP).

Key Points:

  • Advisory boards provide crucial support for physicians' clinical decisions in treating pregnant cancer patients.

Related Experiment Videos

  • The Danish Advisory Board on Cancer in Pregnancy (DABCIP) is a multidisciplinary initiative with 22 members across 13 medical fields.
  • International collaboration and specialized boards are essential for advancing the care of this patient population.

    • Conclusions:

    • The establishment of specialized advisory boards signifies a growing commitment to improving the care of pregnant cancer patients.
    • Multidisciplinary collaboration through such boards is vital for addressing the unique challenges of cancer in pregnancy.
    • Continued knowledge sharing and support structures are necessary to enhance physician confidence and patient outcomes.